Edesa Biotech, Inc. (EDSA): Operating Income
-$7.91M
Year ended 2025-09-30
-$14.63M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$7.91M | n/m | 2025-12-12, From 2024-10-01 |
| 2024-09-30 | -$7.01M | n/m | 2025-12-12, From 2023-10-01 |
| 2023-09-30 | -$9.22M | n/m | 2024-12-13, From 2022-10-01 |
| 2022-09-30 | -$18.37M | n/m | 2023-12-15, From 2021-10-01 |
| 2021-09-30 | -$23.68M | n/m | 2022-12-16, From 2020-10-01 |
| 2020-09-30 | -$6.40M | n/a | 2021-12-28, From 2019-10-01 |
| No annual figure between 2018-09-30 and 2020-09-30. | |||
| 2018-09-30 | -$5.08M | n/m | 2018-11-30, From 2017-10-01 |
| 2017-09-30 | -$5.22M | n/m | 2018-11-30, From 2016-10-01 |
| 2016-09-30 | -$4.91M | n/m | 2017-12-01, From 2015-10-01 |
| 2015-09-30 | -$4.34M | n/a | 2017-12-01, From 2014-10-01 |
| 2014-08-31 | -$5.72M | n/a | 2016-12-14, From 2013-09-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | -$7.91M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$23.12M | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | -$112.00M | n/m |
| CytoDyn Inc. (CYDY) | 2026-05-31 | -$38.58M | n/m |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | -$22.50M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$4.23M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$16.22M | n/m |
| Biovie Inc. (BIVI) | 2026-06-30 | -$22.65M | n/m |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$5.11M | n/m |
Compare EDSA, CALC, CMMB, CYDY side by side · Screen every company in Pharmaceutical Preparations ↗